For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $1.4 in the prior trading day, Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $1.29, down -7.86%. In other words, the price has decreased by -$7.86 from its previous closing price. On the day, 9.25 million shares were traded. ALLO stock price reached its highest trading level at $1.49 during the session, while it also had its lowest trading level at $1.265.
Ratios:
Our goal is to gain a better understanding of ALLO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.71 and its Current Ratio is at 9.71. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.21.
On March 14, 2025, Citizens JMP Upgraded its rating to Mkt Outperform which previously was Mkt Perform but kept the price unchanged to $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 10 ’25 when MESSEMER DEBORAH M. sold 36,885 shares for $1.42 per share. The transaction valued at 52,377 led to the insider holds 107,431 shares of the business.
MESSEMER DEBORAH M. bought 36,885 shares of ALLO for $52,391 on Jun 10 ’25. On Apr 21 ’25, another insider, Yoshiyama Annie, who serves as the SVP, Finance of the company, sold 9,601 shares for $1.41 each. As a result, the insider received 13,537 and left with 130,663 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 282162976 and an Enterprise Value of 91042744.
Stock Price History:
The Beta on a monthly basis for ALLO is 0.38, which has changed by -0.5291971 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, ALLO has reached a high of $3.78, while it has fallen to a 52-week low of $0.86. The 50-Day Moving Average of the stock is 1.30%, while the 200-Day Moving Average is calculated to be -28.80%.
Shares Statistics:
The stock has traded on average 3.42M shares per day over the past 3-months and 3899950 shares per day over the last 10 days, according to various share statistics. A total of 218.60M shares are outstanding, with a floating share count of 149.51M. Insiders hold about 31.65% of the company’s shares, while institutions hold 67.43% stake in the company. Shares short for ALLO as of 1752537600 were 25930643 with a Short Ratio of 7.58, compared to 1749772800 on 26041918. Therefore, it implies a Short% of Shares Outstanding of 25930643 and a Short% of Float of 14.35.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The company has 11.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.19 and low estimates of -$0.29.
Analysts are recommending an EPS of between -$0.74 and -$1.2 for the fiscal current year, implying an average EPS of -$1.01. EPS for the following year is -$1.01, with 11.0 analysts recommending between -$0.55 and -$1.47.
